Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS043954-03
Application #
6663210
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (10))
Program Officer
Kleitman, Naomi
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
3
Fiscal Year
2003
Total Cost
$467,160
Indirect Cost
Name
Cognosci, Inc.
Department
Type
DUNS #
141881727
City
Research Triangle Park
State
NC
Country
United States
Zip Code
27709
Laskowitz, Daniel T; McKenna, Suzanne E; Song, Pingping et al. (2007) COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J Neurotrauma 24:1093-107
Wang, H; Durham, L; Dawson, H et al. (2007) An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 144:1324-33
Mesis, Rachel G; Wang, Haichen; Lombard, Frederick W et al. (2006) Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 21:E4
Qiang, Wenan; Kuang, Xianghong; Liu, Jinrong et al. (2006) Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J Virol 80:3273-84
Gao, Junling; Wang, Haichen; Sheng, Huaxin et al. (2006) A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 4:25-31
Li, Feng-Qiao; Sempowski, Gregory D; McKenna, Suzanne E et al. (2006) Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther 318:956-65
Laskowitz, D T; Fillit, H; Yeung, N et al. (2006) Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease. Acta Neurol Scand Suppl 185:15-20